Innate Pharma SA Cash Flows From Used In Operations Before Changes In Working Capital
Innate Pharma SA (IPHYF) reported Cash Flows From Used In Operations Before Changes In Working Capital of -EUR 42.12 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-04-01.
Financial Statements › Notes
ifrs-full:CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital · last filed 2026-04-01
| Period end | Cash Flows From Used In Operations Before Changes In Working Capital 6 month | Cash Flows From Used In Operations Before Changes In Working Capital 12 month |
|---|---|---|
| 2025-12-31 | -42.12M EUR 20-F · filed 2026-04-01 | |
| 2025-06-30 | -16.99M EUR 6-K · filed 2025-09-17 | |
| 2024-12-31 | -46.06M EUR 20-F · filed 2026-04-01 | |
| 2024-06-30 | -23.56M EUR 6-K · filed 2025-09-17 | |
| 2023-12-31 | -467.00K EUR 20-F · filed 2026-04-01 | |
| 2023-06-30 | 7.07M EUR 6-K · filed 2024-09-12 | |
| 2022-12-31 | -6.65M EUR 20-F · filed 2025-04-30 | |
| 2022-06-30 | 12.19M EUR 6-K · filed 2023-09-14 | |
| 2021-12-31 | -48.57M EUR 20-F · filed 2024-04-04 | |
| 2021-06-30 | -18.52M EUR 6-K · filed 2022-09-15 | |
| 2020-12-31 | -2.56M EUR 20-F · filed 2023-04-06 | |
| 2020-06-30 | -430.00K EUR 6-K · filed 2021-09-15 | |
| 2019-12-31 | -5.32M EUR 20-F · filed 2022-04-04 | |
| 2018-12-31 | 14.57M EUR 20-F · filed 2021-04-27 | |
| 2017-12-31 | -31.08M EUR 20-F · filed 2020-04-24 |